Health Canada
Document 10122241
Fields
- Notes
Selected on visit 1 (May 1999)
- Site
- Guildford
Document Images
RACIJJI62C
24th March, ]981
..
FLAVOUR DEGRADATION STUDIES
REVIEW MEETING
I.
2.
3e
4.
5.
Present:
Mr. A.G. Barnes
Dr. P.O. ~van
Dr. R.A. Crellin
Mr. T.G. Mitchell
Dr. P.S. Stewart.
In the near future, screening work involving cembratrienediol (CBD),
manool, ambroxide, 8-1onone and ambrettolide will be complete.
The reproducibility of the system will be assessed by
rescreening selected organisms. Larger scale reaction with organisms
which cause high conversion of substrate into a small number of
products will then be carried out.
Product mixtures will be passed to PCB/PSS for Prep/SemlprepLC into
product materials for identification by nmr and ms.
LC work will be
time consuming and requires either:
a] an extra palr of skilled hands or
b) a temporary halt to other project work.
Screening of organisms against 8-carotene and re-screening against
abienol is Justified. Solvent problems may be encountered with
B-carotene and Vitamin A acetate may he substituted.
Evidence to date suggests that primary reaction due to micro-organisms
is hydroxylation. Consequently, two-step approach may be adopted as
follows:
BATCo document for Legal Services • Health Canada 20 May 1999

- 2-
(i) B-Carotene
mtcrob¢o ~ Lutein etc.
~
photoche~
Bydroxylonones, Hydroxydamascones etc.
(ii) Abienol
microbio
Hydroxyabienol
~
pho~x~.hem
Novel series of ~droxynorlabdanolds.
This is appealing, since literature information is that hydroxy derlvatlves
are more tobacco-llke and have lower flavour thresholds.
6,
7b
8,
Ketolsophorone ks available and should be screened. The normal
position of reaction is blocked and this might induce other reaction
types.
Crombie (Notts. Univ.} might be approached to consider chemical routes
to hydroxy derivatives.
Cambie/Grant (N.Z.) should be approached for norlabdanes which they
have synthesised. If available, these would add to our understanding
of the underlying structural features which convey tobacco flavour.
9. Next meeting April 27th,
Distribution:
Mr. A.G. Barnes.
Dr. P.C. Bevan.
Mr. T.G. Mitche11.
Dr. P.S. Stewart.
lO.30ata.
R.A. CRELLIN
CD
BATCo document for Legal Services • Health Canada 20 May 1999

Dr. P.C. Bevan/Mr. A.G. Barnes/AH/62C
3rdMarch, 1982.
B I 0 L 0 G I C A L-C H E M I C AL C 0 L LAB 0 EAT I 0 N
PROGRESS MEETING - 2NDMARCH 1982
Present: Mr. A.G. Barnes
Dr. P.C. Bevan
Mr. D.A. Johnson
The meeting was convened to review p~ogress todate and to
agree the work progr~z~e for the next few months.
A. PLANT CELL CULTURE WORK /
U-CBD when fed to a Palotina plant cell culture (ex Sheffield)
gave a number of more polar products. These will be looked at by
GC and GC-MS.
The following experiments will be run next:
u-CBD with Izmir and NC2326
B-CBD with Izmir, NC2326 and Palotina
In addition (12Z)-abienol could be examined, although this
compound is inherently less stable to heat and light and thus
presents handling problems.
B. MICROBIAL DEGRADATION WORK
Achieved to Date
i) DeEradation of sclareol to three products in good yield.
No further work planned on this compound.
ii) Degradation of 8-1onone to a range of Cl$ and Cll compounds.
The CIs compounds, some of which are knownaroma compounds,
have also been obtained by Japanese workers (JTS) but the
CII co~potmds are novel. However they do not seem to be of
great potential as tobacco flavourants. Do not plan to
pursue this further.
iii) Degradation of u-lonone has recently been started. The
initial product is a-ionol. The reduction will very possibly
be stereoselective, which would differentiate it from the
(easily performed) chemical reduction.
v~o
BATCo document for Legal Services • Health Canada 20 May 1999

-2-
iv) Degradation of a-CBD to more polar products. Two of these
have been identified by spectroscopic techniques as I and
~I. (I is a known tobacco constituent, while II is a new
compound.)
v) B-CBD, Ambroxide, Ambrettolide and manool have been screened
and promising organisms have been identified.
Next Steps
i) The ~-ionone degradati~n~rill be allowed to progress further
and will be monitored bY GC to determine the optimum time
at which to halt the fermentation. Products ~ill be separated
and tested on cigarettes. 3-0xo-~-ionone (obtained from
B.A.T. Hamburg) is available as a reference compound to aid
identification.
ii) B-CBD will be degraded and products identified, to complement
the results alrady obtained from the ~-isomer. (Screening
already carried out.) Organism: ¥310.
iii) The potent aroma compound ambroxide willbe degraded to
products in which it is hoped the aroma will be intensified/
f?l~
modified. (Screening already done.) Orsanism will be E3~e
and/or F318.
iv) Another diterpenold of potential use is man~ol; F318 will
be used initially.
A.G. BARNES P.C. BEVAN
Distribution
Mr. A.G. Barnes
Mr. M.A. Baylis
Dr. P.C. Bevah
PCB/AGB/AH/62C
3rd March, 1982.
Dr. E.A. Crellln
Mr. D.A. Johnson
Mr. T.G. Mitchell
r~D
r~c
BATCo document for Legal Services • Health Canada 20 May 1999

.~ o~v,c~S
/
I
K
:E
P,j
P~j
r,,j
r,~
BATCo document for Legal Services • Health Canada 20 May 1999
